Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis.

Volume: 79, Issue: 9, Pages: 1243 - 1249
Published: Sep 1, 2020
Abstract
Objectives null Evaluation of rituximab and glucocorticoids as therapy to induce remission after relapse in ANCA-associated vasculitis (AAV) in a prospective observational cohort of patients enrolled into the induction phase of the RITAZAREM trial. null Methods null Patients relapsing with granulomatosis with polyangiitis or microscopic polyangiitis were prospectively enrolled and received remission-induction therapy with rituximab (4×375 mg/m2)...
Paper Details
Title
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis.
Published Date
Sep 1, 2020
Volume
79
Issue
9
Pages
1243 - 1249
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.